Skip to Content
Exit

Author Archives: Jorg Lorscheider

  7. FDA Approves New Drug to Treat Niemann-Pick Disease, Type C | FDA

    Leave a Comment

    Sorry for this seemingly out of place article!   Just so happens that my grandniece has Niemann-Pick.  She is 9 years old and probably will not live much longer.  This is a step in the right direction though!  FDA approved Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing at least 15 kg…

    Read the full article at: www.fda.gov

  8. Scalable, At-Home Diagnostics: How SiPhox Delivers with Silicon Photonics | Intel

    Leave a Comment



    In this InTechnology video, Camille chats with episode co-host Srini Ananth, Managing Director at Intel Capital, and guest Michael Dubrovsky, CPO and Co-Founder at SiPhox Health, about silicon photonics in personalized medicine. They discuss the technological advancements and advantages of silicon photonics, its applications in telecom and health diagnostics, the motivations behind Intel Capital’s investment in SiPhox, SiPhox’s innovative approach to personalized diagnostics, safeguarding personal health data, the role of AI in healthcare, and much more.

    0:00 Introductions
    2:08 What is silicon photonics?
    4:21 How SiPhox uses silicon photonics
    6:12 SiPhox’s at-home tests and devices
    8:20 Intel Capital’s interest in SiPhox
    11:18 Quantitative tests vs. on/off tests
    13:07 SiPhox’s unique market testing approach
    16:17 Security and AI for personal health data
    19:25 Risk vs. opportunities
    21:31 Wrap-up

    Learn more about Intel Capital: https://www.intelcapital.com/

    For more information, previous podcasts, and full versions, visit our website at https://intechnology.intel.com/

    #siliconphotonics #personalizedmedicine #personalizeddiagnostics #SiPhox #IntelCapital

    The views and opinions expressed are those of the guests and author and do not necessarily reflect the official policy or position of Intel Corporation.

    If you are interested in emerging threats, new technologies, or best tips and practices in cybersecurity, please follow the InTechnology podcast on your favorite podcast platforms.

    Apple Podcast: https://podcasts.apple.com/il/podcast/intechnology/id1526572021
    Spotify: https://open.spotify.com/show/6RN4ATo5ZDGvgaEj8rLep7?si=EQyu5_A0RvaEDGMdmiiRug

    Follow our host Camille @morhardt on X: https://twitter.com/morhardt/

    Subscribe now to Intel on YouTube: https://intel.ly/3IX1bN2

    About Intel:
    Intel, the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Founded in 1968 to build semiconductor memory products, Intel introduced the world’s first microprocessor in 1971. This decade, our mission is to create and extend computing technology to connect and enrich the lives of every person on Earth.

    Connect with Intel:
    Visit Intel WEBSITE: https://intel.ly/Intel
    Follow Intel on X: https://intel.ly/Twitter
    Follow Intel on INSTAGRAM: https://intel.ly/Instagram
    Follow Intel on LINKEDIN: https://intel.ly/LinkedIn
    Follow Intel on TIKTOK: https://intel.ly/TikTok

    Scalable, At-Home Diagnostics: How SiPhox Delivers with Silicon Photonics | Intel
    https://www.youtube.com/intel

    Read the full article at: www.youtube.com